Tucatinib and Abemaciclib: Interaction Details

Brand names
Tucatinib
Tukysa
Abemaciclib
Verzenio
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Tucatinib With Abemaciclib

What can happen when they are taken together (rated Major)

Increased exposure to and risk of toxicity

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Tucatinib should not be combined with a CYP3A substrate when even small changes in the substrate's concentration could result in serious or life-threatening toxicity. A clinical study found that giving tucatinib together with midazolam, a CYP3A substrate, markedly raised both the and of midazolam. When the two drugs must be given together, the dosage of the CYP3A substrate should be lowered.1

The Tucatinib and Abemaciclib Interaction, Explained

Tucatinib can raise the amount of abemaciclib in your body. Tucatinib slows down , a liver enzyme that helps clear abemaciclib. When that enzyme is slowed, abemaciclib can build up, which may make side effects stronger. Abemaciclib is already known to cause diarrhea, low blood cell counts, tiredness, and sometimes liver changes.

Please keep taking both medicines as prescribed. Talk with your pharmacist or doctor about this combination. Your care team can manage it by adjusting and individualizing the abemaciclib dose and by monitoring you more closely.

Mechanism: Tucatinib inhibits -mediated . Abemaciclib is a (active drug, not a ), so is expected to increase abemaciclib and active exposure.

  • Evidence: Probable. Tucatinib significantly increased midazolam and in a clinical study. Abemaciclib-specific data are not cited here.
  • Onset: Unspecified.
  • Risk: Increased abemaciclib toxicity (diarrhea, , , VTE).
  • Management: Avoid if possible. If coadministration is required, reduce the CYP3A substrate dose (abemaciclib), individualize, and monitor closely for adverse effects.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Tucatinib and Abemaciclib Interact

The likely mechanism

of -mediated by tucatinib

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Tucatinib and Abemaciclib Interaction

Keep taking both medicines as prescribed unless your care team tells you otherwise.

  • Your care team may try to avoid this combination where possible.
  • If both are needed, the abemaciclib dose may need to be reduced, adjusted, and individualized by your care team.
  • Your team may monitor you more closely for side effects.
  • Tell your pharmacist or prescriber about any new or worsening symptoms, such as diarrhea, unusual tiredness, or signs of infection.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Tucatinib or Abemaciclib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: TUKYSA oral tablets, tucatinib oral tablets

    In a clinical study, a single 2 mg dose of midazolam (a with a ) was given together with tucatinib 300 mg twice daily at . The ratio of midazolam exposure with versus without tucatinib was 5.7 for and 3 for .1

Tucatinib and Abemaciclib: Common Questions

How serious is the Tucatinib and Abemaciclib interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Tucatinib and Abemaciclib interaction managed?

Keep taking both medicines as prescribed unless your care team tells you otherwise. Your care team may try to avoid this combination where possible. If both are needed, the abemaciclib dose may need to be reduced, adjusted, and individualized by your care team. Your team may monitor you more closely for side effects. Tell your pharmacist or prescriber about any new or worsening symptoms, such as d… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Tucatinib and Abemaciclib Interaction

Ask in your own words about taking Tucatinib and Abemaciclib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: TUKYSA(TM) oral tablets, tucatinib oral tablets. Seattle Genetics Inc (per FDA), Bothell, WA, 2020. DailyMed
Was this write-up helpful?

Other Serious Interactions of Tucatinib and Abemaciclib

Also serious with Tucatinib

Also serious with Abemaciclib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Tucatinib

With Abemaciclib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.